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C-type lectin receptors (CLRs) constitute
a family of pattern recognition receptors
(PRRs), many of which are involved in
immunity [1]. Of particular interest are
signaling CLRs whose encoding genes are
located in the Dectin-1 and Dectin-2 clus-
ter of receptors [2, 3]. Many of these CLRs
play key roles in immunity to fungi, includ-
ing Candida, Aspergillus, and Cryptococcus
[1–3]. These receptors, Dectin-1, Dectin-
2, Mincle, MCL, and MelLec, recognize lig-
ands in the fungal cell wall and are able
to induce intracellular signaling directly
through integral, or membrane associated,
signaling domains or by association with a
signaling partner [1].
Most of these “antifungal” CLRs are
thought to be expressed by myeloid cells,
but there is some evidence suggesting
that these receptors are also expressed
on nonmyeloid cells including endothe-
lial and epithelial cells [4–8]. Indeed, we
recently identified MelLec as a novel anti-
fungal CLR that was primarily expressed
by endothelial cells [9]. Epithelial and
endothelial cells are known to be involved
in controlling inflammatory, immune and
regenerative responses in several diseases
(including asthma) but our understand-
ing of the role of these cells during fun-
gal infections is still poorly understood. We
therefore undertook a systematic explo-
ration of antifungal CLR expression on
epithelial and endothelial cells at mucosal
surfaces of the respiratory, gastrointesti-
nal, and genital-urinary tract, which are
commonly exposed to fungal pathogens.
In the literature, a range of proteolytic
enzymes have been used for the genera-
tion of single cell suspensions of tissues.
However, these treatments can affect the
levels of surface molecules and have func-
tional consequences [10]. Little is known
about the impact of such treatment on
the expression and function of CLRs. We
therefore investigated the effect of com-
monly used proteolytic enzymes on the
ability to detect surface expression of
CLRs. For these evaluation experiments,
we made use of NIH3T3 cells overex-
pressing Dectin-1, Mincle, MCL, MelLec,
or Dectin-2, which were treated with a
variety of the most commonly used tissue-
dissociation enzymes. Following enzy-
matic treatment, we assessed CLR expres-
sion by flow cytometry and observed
that detection of Dectin-1 expression was
markedly decreased upon incubation with
most enzymes (Fig. 1A and Supporting
Information Fig. S1A and B). The reduc-
tion in Dectin-1 surface expression was
not unexpected, as its protease-sensitivity
has been characterized previously [1, 11].
MCL was similarly decreased upon incu-
bation with most enzymes (Fig. 1B), but
detection of both MCL and Dectin-1 was
least affected following treatment using
the lung dissociation kit (Fig. 1A and B and
Supporting Information Fig. S1B and C).
Detection of Mincle was markedly reduced
upon incubation with all enzymes tested































































D = Collagenase 
E = Lung dissociation kit
Figure 1. Effect of enzymatic digestion on
C-type lectin receptor expression on NIH3T3
cells. Median fluorescence intensity (MFI) of
CLR expression, as determined by flow cytom-
etry, on NIH3T3 cells overexpressing Dectin-
1 (A), MCL (B), Mincle (C), MelLec (D), and
Dectin-2 (E) after incubation with enzymes
(as described) represented as percentage of
untreated (UT) cells. Error bars represent
mean ± SEM of pooled data from three inde-
pendent experiments.
(Fig. 1C and Supporting Information Fig.
S1D). In contrast, detection of MelLec
and Dectin-2 was largely unaffected by
digestion with any of the enzymes tested
(Fig. 1D and E and Supporting Informa-
tion Fig. S1E and F). Thus, enzymatic
digestion can significantly influence the
ability to detect expression of some CLRs
on cells.
Using the lung dissociation kit, which
had the least effect on the ability to
detect CLR surface expression, we next
assessed the expression of these receptors
on murine lung epithelial and endothe-
lial cells ex vivo. As we have previ-
ously observed [9], expression of Mel-
Lec could be detected on naïve lung
CD45–CD31+ endothelial cells (Fig. 2A
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Figure 2. Expression of C-type lectin receptors on epithelial and endothelial populations of the murine mucosal surfaces. Flow-cytometric plots of
CLR expression (representative of two independent experiments, first experiment three individual mice, second experiment on cells pooled from
two mice) on single, live, CD45–CD31+ endothelial cells (A) and CD45−EpCAM+ epithelial cells (B) in the naïve lung. Flow-cytometric plots of CLR
expression (cells pooled from five mice, one experiment. CLEC-1 expression, three independent experiments, second and third experiment on cells
pooled from three mice) on single, live, CD45–CD31+ endothelial cells (C) and CD45−EpCAM+ epithelial cells (D) in the genital-urinary tract. Flow-
cytometric plots of CLR expression (cells pooled from three mice, one experiment. CLEC-1 expression, three independent experiments, second and
third experiment on cells pooled from twomice) on single, live, CD45–CD31+ endothelial cells (E) and CD45−EpCAM+ epithelial cells (F) in the small
intestine. Lines represent expression of CLR (red) and isotype control (black).
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and Supporting Information Fig. S2A).
However, we did not detect MelLec expres-
sion on CD45–CD31–EpCAM+ epithelial
cells (Fig. 2B). To confirm this result,
we investigated MelLec expression on the
three major epithelial cell subtypes in the
lung. Epithelial cell subset specific pro-
moters driving EGFP expression were used
to identify type II alveolar (Sftpc), club
(Scgb1a1), and ciliated (Foxj1) epithelial
cells. These data confirm that expression
of MelLec is absent on all three major
epithelial populations (Supporting Infor-
mation Fig. S2B and C).
To determine if expression of Mel-
Lec could be modulated under inflam-
matory conditions, we intratracheally
infected mice with Aspergillus fumigatus
and assessed receptor expression after 24
h. We determined that expression of Mel-
Lec was unaltered on lung CD45–CD31+
endothelial cells (Supporting Information
Fig. S2D), and remained undetectable on
CD45–EpCAM+ cells (Supporting Informa-
tion Fig. S2E). Thus, expression of MelLec
is unaltered by inflammatory conditions.
Several reports have suggested that
other anti-fungal CLRs can be expressed
by endothelial and/or epithelial cells [4–
8]. We therefore explored the expres-
sion of Dectin-1, Dectin-2, Mincle, and
MCL in naïve and infected mouse lungs,
as described above. Notably, we did not
detect expression of any of these recep-
tors on endothelial or epithelial under
any conditions tested (Fig. 2A and B and
Supporting Information Fig. S2D and E).
We cannot exclude, however, that expres-
sion of CLRs may be upregulated under
other inflammatory conditions. Although
the inability to detect Mincle expres-
sion could be due to enzymatic diges-
tion (Fig. 1C), the absence of MCL sup-
ports our conclusion, as these receptors
form a heterodimer that is required for
surface expression [1], that is, absence of
MCL would correlate with absence of Min-
cle. Thus, we conclude that MelLec is the
only antifungal CLR we examined that is
expressed on nonmyeloid cells in the lung
in the mouse.
Finally, we explored CLR expression on
nonmyeloid cells at two other mucosal tis-
sues frequently in contact with fungi, the
genital-urinary and gastrointestinal tract.
Similar to the lung, only MelLec was
detected on naïve CD45–CD31+ endothe-
lial cells, and no CLRs were detected
on CD45–EpCAM+ epithelial cells of the
genital-urinary tract (Fig. 2C and D and
Supporting Information Fig. S2F). Unfor-
tunately, the lung dissociation kit was
not suitable for generating viable, sin-
gle cell populations of the small intes-
tine for analysis and we had to resort to
using Collagenase VIII to analyze this tis-
sue. As before, only MelLec was detected
on CD45–CD31+ endothelial cells, and no
CLRs were detected on CD45–EpCAM+
epithelial cells isolated from the gastroin-
testinal tract (Fig. 2E and F and Sup-
porting Information Fig. S2G). The caveat
with the latter experiment being the signif-
icantly reduced ability to detect Dectin-1,
MCL, and Mincle using this tissue diges-
tion method (Fig. 1 and Supporting Infor-
mation Fig. S1). Thus, the expression of
these antifungal CLRs on mucosal non-
myeloid cells appears limited to MelLec
on endothelial cells. Previous reports have
also suggested expression of Dectin-1 on
a wider range of nonmyeloid cells in
humans [4–7], raising the possibility of
differential expression of this CLR between
species. This is a focus of our future stud-
ies.
In summary, our data reveal that the
selection of enzymes for generating sin-
gle cell suspensions from murine tissues
influences the detection of surface expres-
sion of antifungal CLRs, which may have
consequences in subsequent in vitro anal-
yses [1, 11]. Using a digestion method that
most preserves receptor surface expres-
sion, we show that nonmyeloid expression
of antifungal CLRs is limited to MelLec on
endothelial cells in mucosal tissues of the
respiratory, gastrointestinal, and genital-
urinary tracts in mice, at least at the pro-
tein level by flow cytometry.
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